Kron A, Scheffler M, Wiesweg M, Hummel HD, et al. Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations. Eur J Cancer 2024;207:114158.
PMID: 38941869